Skip to main content
OpenTrials

Clinical trial condition

Glomerulonephritis, Membranoproliferative

Explore clinical trials studying Glomerulonephritis, Membranoproliferative. Study availability and eligibility vary by location and protocol.

23 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Glomerulonephritis, Membranoproliferative trial results

Recruiting

Chinese Adults With Kidney Disease

NCT07522099

Conditions
Autoimmune Diseases, Complement 3 Glomerulopathy (C3G), Female Urogenital Diseases, +12 more
Locations
  • ADARx Clinical Site Shenzhen, Guangdong, China
  • ADARx Clinical Site Guiyang, Guizhou, China
  • ADARx Clinical Site Zhengzhou, Henan, China
  • ADARx Clinical Site Baotou, Inner Mongolia, China
View Trial Details
Recruiting

Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS

NCT05795140

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +18 more
Locations
  • Novartis Investigative Site São Paulo, Brazil
  • Novartis Investigative Site Rio de Janeiro, Brazil
  • Novartis Investigative Site Beijing, China
  • Novartis Investigative Site Ostrava, Poruba, Czechia
View Trial Details
Completed

Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN

NCT04572854

Conditions
C3 Glomerulonephritis, C3 Glomerulopathy, C3G, +19 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Keck School of Medicine, University of Southern California Los Angeles, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Mayo Clinic Rochester, Minnesota, United States
View all 25 locations
View Trial Details
Completed

Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

NCT05067127

Conditions
C3 Glomerulonephritis, C3 Glomerulopathy, C3G, +19 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Academic Medical Research Institute Los Angeles, California, United States
  • Keck School of Medicine, University of Southern California Los Angeles, California, United States
  • Ronald Reagan UCLA Medical Center (01035) Los Angeles, California, United States
View all 125 locations
View Trial Details
Completed

Controlled Trial Evaluating Avacopan in C3 Glomerulopathy

NCT03301467

Conditions
C3 Glomerulopathy (C3G), Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +8 more
Locations
  • Clinical Site Palo Alto, California, United States
  • Clinical Site Chicago, Illinois, United States
  • Clinical Site Iowa City, Iowa, United States
  • Clinical Site Boston, Massachusetts, United States
View all 45 locations
View Trial Details

Related conditions